DE60230984D1 - Moraxella (branhamella) catarrhalis antigene - Google Patents

Moraxella (branhamella) catarrhalis antigene

Info

Publication number
DE60230984D1
DE60230984D1 DE60230984T DE60230984T DE60230984D1 DE 60230984 D1 DE60230984 D1 DE 60230984D1 DE 60230984 T DE60230984 T DE 60230984T DE 60230984 T DE60230984 T DE 60230984T DE 60230984 D1 DE60230984 D1 DE 60230984D1
Authority
DE
Germany
Prior art keywords
branhamella
catarrhalis
moraxella
antigene
prophylaxis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60230984T
Other languages
German (de)
English (en)
Inventor
Denis Martin
Josee Hamel
Bernard R Brodeur
Stephane Rioux
Genevieve Leblanc
Julie Couture
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ID Biomedical Corp of Quebec
Original Assignee
ID Biomedical Corp of Quebec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ID Biomedical Corp of Quebec filed Critical ID Biomedical Corp of Quebec
Application granted granted Critical
Publication of DE60230984D1 publication Critical patent/DE60230984D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Otolaryngology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60230984T 2001-06-18 2002-06-18 Moraxella (branhamella) catarrhalis antigene Expired - Fee Related DE60230984D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US29840301P 2001-06-18 2001-06-18
US33009501P 2001-10-19 2001-10-19
PCT/CA2002/000911 WO2002102836A2 (en) 2001-06-18 2002-06-18 Moraxella (branhamella) catarrhalis antigens

Publications (1)

Publication Number Publication Date
DE60230984D1 true DE60230984D1 (de) 2009-03-12

Family

ID=26970641

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60230984T Expired - Fee Related DE60230984D1 (de) 2001-06-18 2002-06-18 Moraxella (branhamella) catarrhalis antigene

Country Status (8)

Country Link
US (1) US20050080233A1 (enExample)
EP (2) EP1399563B1 (enExample)
JP (1) JP2005508146A (enExample)
CN (1) CN1582336A (enExample)
AT (1) ATE421586T1 (enExample)
CA (1) CA2455254A1 (enExample)
DE (1) DE60230984D1 (enExample)
WO (1) WO2002102836A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110540594B (zh) * 2018-12-20 2021-05-11 湖北工业大学 基于卡他莫拉菌表面蛋白的乳胶微球免疫层析试纸的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US4338397A (en) 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
GB9817824D0 (en) * 1998-08-14 1998-10-14 Smithkline Beecham Biolog Novel compounds
AU1824101A (en) * 1999-06-18 2001-01-09 Elitra Pharmaceuticals, Inc. Nucleotide sequences of moraxella catarrhalis genome

Also Published As

Publication number Publication date
EP2166096A2 (en) 2010-03-24
CA2455254A1 (en) 2002-12-27
WO2002102836A3 (en) 2003-05-22
EP1399563A2 (en) 2004-03-24
EP1399563B1 (en) 2009-01-21
EP2166096A3 (en) 2010-06-09
JP2005508146A (ja) 2005-03-31
ATE421586T1 (de) 2009-02-15
CN1582336A (zh) 2005-02-16
US20050080233A1 (en) 2005-04-14
WO2002102836A2 (en) 2002-12-27

Similar Documents

Publication Publication Date Title
DK2000545T3 (da) Sammensætninger og fremgangsmåder til diagnose og behandling af lunge-tumor
SE0102315D0 (sv) Compounds
DK0758904T3 (da) Fremgangsmåder og sammensætninger til behandling af glomerulonephritis
IL149459A0 (en) Recombinant gelatins
DE60233955D1 (de) Spezifische bindungsmittel von human angiopoietin-2
ATE305793T1 (de) Bakteriophage mit breitem wirtspektrum
BRPI0414062A (pt) uso de ciclosporinas midificadas para o tratamento de distúrbios por hcv
IL189629A0 (en) Compositions containing human ctla-4 antibodies
SE0203825D0 (sv) Novel fused heterocycles and uses thereof
CY1114614T1 (el) Αντιγονα αιμοφιλου ινφλουεντσας και αντιστοιχα dna θραυσματα
ATE363531T1 (de) Claudin polypeptide
ATE453714T1 (de) Antigene aus cryptosporidium parvum, antikörper dagegen und diagnostische und therapeutische zusammensetzungen
BR0113099A (pt) Gene e proteìna relacionados com esquizofrenia
DE60229845D1 (de) Moraxella (branhamella) catarrhalis antigene
DE60230984D1 (de) Moraxella (branhamella) catarrhalis antigene
DK1276495T3 (da) Anvendelse af rekombinante lungesurfactant-præparater til tidlig behandling af akutte lungesygdomme
ATE112168T1 (de) Menschlicher hitzeschock-faktor.
ATE398134T1 (de) Neue analoga von nitrobenzylthioinosin
ATE414155T1 (de) Moraxella (branhamella) catarrhalis polypeptide
DK1078064T3 (da) Forbindelser fra moraxella catarrhalis
WO2003018052A8 (en) Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments
ATE312922T1 (de) Moraxella catarrhalis polynukleotide und polypeptide
MXPA04004757A (es) Uso de una ascomicina para el tratamiento de blefaritis.
DE60019614D1 (de) Moraxella catarrhalis antigen basb117
ATE293692T1 (de) Moraxella catarrhalis antigen basb120

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee